MA26553A1 - Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la - Google Patents

Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la

Info

Publication number: MA26553A1
Authority: MA; Morocco
Prior art keywords: alkylnitrones; aryl; alpha; same; pharmaceutical compositions
Prior art date: 1997-10-17

Application number

MA25299A

Other languages

English (en)

Inventor

Judith A Kelleher

Kirk R Maples

Allan I Wilcox

Alina Dykman

Yong-Kang Zhang

Julian Levell

Original Assignee

Centaur Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-17

Filing date

1998-10-15

Publication date

2004-12-20

1998-10-15 Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc

2004-12-20 Publication of MA26553A1 publication Critical patent/MA26553A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
- C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Transplantation (AREA)
Pulmonology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

MA25299A 1997-10-17 1998-10-15 Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la MA26553A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US6232497P	1997-10-17	1997-10-17
US6373697P	1997-10-29	1997-10-29
US9047598P	1998-06-24	1998-06-24

Publications (1)

Publication Number	Publication Date
MA26553A1 true MA26553A1 (fr)	2004-12-20

Family

ID=27370256

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25299A MA26553A1 (fr)	1997-10-17	1998-10-15	Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la

Country Status (24)

Country	Link
US (5)	US6046232A (fr)
EP (1)	EP1025079B1 (fr)
JP (1)	JP2001520217A (fr)
KR (1)	KR20010024520A (fr)
CN (1)	CN1281432A (fr)
AR (1)	AR015969A1 (fr)
AT (1)	ATE288419T1 (fr)
AU (1)	AU1083399A (fr)
BR (1)	BR9813256A (fr)
CA (1)	CA2305798A1 (fr)
DE (1)	DE69828895T2 (fr)
ES (1)	ES2235374T3 (fr)
HU (1)	HUP0004398A3 (fr)
ID (1)	ID25543A (fr)
IL (1)	IL135646A0 (fr)
MA (1)	MA26553A1 (fr)
NO (1)	NO20001914L (fr)
NZ (1)	NZ503910A (fr)
PL (1)	PL340003A1 (fr)
SK (1)	SK5512000A3 (fr)
TN (1)	TNSN98187A1 (fr)
TR (1)	TR200001023T2 (fr)
TW (1)	TWI226882B (fr)
WO (1)	WO1999020601A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6046232A (en) *	1997-10-17	2000-04-04	Centaur Pharmaceuticals, Inc.	α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
CA2332398A1 (fr)	1998-05-19	1999-11-25	Ian Irwin	Medicament a base de benzamide, destine au traitement des affections inflammatoires de l'intestin
WO1999059576A1 (fr) *	1998-05-19	1999-11-25	Centaur Pharmaceuticals, Inc.	Medicament a base d'arylnitrone, destine au traitement des affections inflammatoires de l'intestin
US6083989A (en) *	1999-05-18	2000-07-04	Centaur Pharmaceuticals, Inc.	Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
WO2000003977A1 (fr)	1998-07-17	2000-01-27	Centaur Pharmaceuticals, Inc.	Composes de alpha-2(2-hydroxyphenyl)nitrone, compositions pharmaceutiques les renfermant et leur utilisation dans le traitement des inflammations
US6730700B2 (en) *	1998-12-02	2004-05-04	Renovis, Inc.	3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
UA66401C2 (en) *	1998-12-02	2004-05-17	Sentor Pharmaceuticals Inc	3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
BR9904931A (pt) *	1999-10-18	2001-06-12	Sergio Teixeira Ferreira	Inibição de amiloidoses
AU1917301A (en) *	1999-11-18	2001-05-30	Centaur Pharmaceuticals, Inc.	Aryl nitrone therapeutics and methods for treating inflammatory bowel disease
US6444702B1 (en)	2000-02-22	2002-09-03	Neuromolecular, Inc.	Aminoadamantane derivatives as therapeutic agents
US6664297B1 (en)	2000-10-18	2003-12-16	Universidade Federal Do Rio De Janeiro	Methods for inhibition and dissolution of amyloidoses by administration of compositions comprising 2,4-dinitrophenol
US20040122090A1 (en) *	2001-12-07	2004-06-24	Lipton Stuart A.	Methods for treating neuropsychiatric disorders with nmda receptor antagonists
WO2002065993A2 (fr) *	2001-01-08	2002-08-29	Centaur Pharmaceuticals, Inc.	Utilisation de composes d'arylnitrone dans des methodes de traitement des douleurs neuropathiques
JP2004527520A (ja) *	2001-04-02	2004-09-09	パノラマリサーチ，インコーポレイティド	治療剤としての抗酸化ニトロキシドおよびニトロン
US7115666B2 (en) *	2002-10-15	2006-10-03	Renovis, Inc.	Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
US6762322B1 (en)	2002-12-20	2004-07-13	Goodyear Tire & Rubber Company	Preparation of nitrone derivatives
EP1622554A4 (fr) *	2003-05-15	2008-01-02	Bioform Medical Inc	Compositions contenant un melange d'un agent pharmaceutique ou d'un agent cosmetique et d'un aldehyde aromatique de support de groupe oxy
US20050059638A1 (en) *	2003-08-04	2005-03-17	Kelly Michael G.	Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
US20050182060A1 (en) *	2004-02-13	2005-08-18	Kelly Michael G.	2-Substituted and 4-substituted aryl nitrone compounds
US7619007B2 (en)	2004-11-23	2009-11-17	Adamas Pharmaceuticals, Inc.	Method and composition for administering an NMDA receptor antagonist to a subject
MX2007012374A (es) *	2005-04-06	2008-02-22	Adamas Pharmaceuticals Inc	Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
FR2898602B1 (fr) *	2006-03-17	2012-06-22	Ts Pharma	Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert butyl nitrone
CN101468970B (zh)	2008-04-25	2011-05-11	暨南大学	一种硝酮类化合物及其制备方法和在制药中的应用
JP5885668B2 (ja)	2009-12-02	2016-03-15	アダマスファーマシューティカルズ，インコーポレイテッド	アマンタジン組成物および使用方法
CN102311396B (zh) *	2010-07-05	2015-01-07	暨南大学	一种吡嗪类衍生物和其制备方法及在制药中的应用
PH12013501427B1 (en)	2011-01-07	2019-02-13	Allergan Inc	Melanin modification compositions and methods of use
WO2014204933A1 (fr)	2013-06-17	2014-12-24	Adamas Pharmaceuticals, Inc.	Compositions d'amantadine et procédés d'utilisation
CN107488090B (zh) *	2017-06-22	2020-06-02	东北师范大学	一种n-环丙基硝酮化合物的高效催化不对称制备方法
CN107522635B (zh) *	2017-06-22	2020-02-14	东北师范大学	一类n-环丙基硝酮衍生物及其制备方法
CN109438288B (zh) *	2018-10-22	2021-05-07	河南中医药大学	一种n-硝酮取代芳香酰胺衍生物及其制备方法
CN112479936A (zh) *	2020-12-16	2021-03-12	怀化学院	一种苯偶酰衍生物硝酮的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3666754A (en) *	1965-11-06	1972-05-30	Dainippon Pharmaceutical Co	2-(5-nitrofuryl) nitrone derivatives
US3849934A (en) *	1971-05-03	1974-11-26	Scm Corp	Alpha-aryl-n-lower alkyl nitrone-containing compositions useful as anti-fungal agents
US3834073A (en) *	1971-05-03	1974-09-10	Scm Corp	Phenyl nitrone derivatives useful as seed protectants
US3903049A (en) *	1974-01-30	1975-09-02	Goodyear Tire & Rubber	Oxidation resistant sulfur curable rubbery polymers
US3917700A (en) *	1974-01-30	1975-11-04	Goodyear Tire & Rubber	Nitrone compounds
IT1133010B (it) *	1980-05-15	1986-07-09	Sigma Tau Ind Farmaceuti	Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo
GB2137619A (en) *	1983-03-30	1984-10-10	Gerald Scott	Nitrone compounds and stabilised rubber compositions containing them
US5352442A (en) *	1985-07-18	1994-10-04	Proctor Peter H	Topical tempo
US5723502A (en) *	1985-07-18	1998-03-03	Proctor; Peter H.	Topical spin trap composition and method
DE68917946T2 (de) *	1988-01-29	1995-01-05	Peter H Proctor	Haarwachstumanregung mit Nitroxyd und anderen Radikalen.
DK0496796T3 (da) *	1989-10-17	1994-10-03	Oklahoma Med Res Found	Fremgangsmåde og præparater til inhibering af sygdomme i forbindelse med oxidativ beskadigelse
CA2111836C (fr) *	1991-06-18	2006-08-29	John M. Carney	Compositions pharmaceutiques a piegeage de spin et methodes d'utilisation correspondantes
US5292746A (en) *	1991-09-12	1994-03-08	Merrell Dow Pharmaceuticals Inc.	Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
US5455272A (en) *	1993-10-22	1995-10-03	Oklahoma Medical Research Foundation	Spin trap nitronyl hindered phenols
US5488145A (en) *	1993-12-23	1996-01-30	Oklahoma Medical Research Foundation	2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
CA2235765C (fr) *	1995-11-17	2006-04-04	David A. Becker	Agents de piegeage de spin a base d'azulenyl-nitrones, et leurs procedes de fabrication et d'utilisation
TW429241B (en) *	1996-09-26	2001-04-11	Sumitomo Pharma	Nitrone derivatives
US6046232A (en)	1997-10-17	2000-04-04	Centaur Pharmaceuticals, Inc.	α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same

1998
- 1998-10-15 US US09/172,763 patent/US6046232A/en not_active Expired - Fee Related
- 1998-10-15 MA MA25299A patent/MA26553A1/fr unknown
- 1998-10-16 KR KR1020007004099A patent/KR20010024520A/ko not_active Ceased
- 1998-10-16 TN TNTNSN98187A patent/TNSN98187A1/fr unknown
- 1998-10-16 AR ARP980105168A patent/AR015969A1/es unknown
- 1998-10-16 ES ES98953466T patent/ES2235374T3/es not_active Expired - Lifetime
- 1998-10-16 SK SK551-2000A patent/SK5512000A3/sk unknown
- 1998-10-16 JP JP2000516943A patent/JP2001520217A/ja active Pending
- 1998-10-16 TR TR2000/01023T patent/TR200001023T2/xx unknown
- 1998-10-16 NZ NZ503910A patent/NZ503910A/xx unknown
- 1998-10-16 AU AU10833/99A patent/AU1083399A/en not_active Abandoned
- 1998-10-16 CN CN98811221A patent/CN1281432A/zh active Pending
- 1998-10-16 IL IL13564698A patent/IL135646A0/xx unknown
- 1998-10-16 PL PL98340003A patent/PL340003A1/xx unknown
- 1998-10-16 ID IDW20000694A patent/ID25543A/id unknown
- 1998-10-16 AT AT98953466T patent/ATE288419T1/de not_active IP Right Cessation
- 1998-10-16 WO PCT/US1998/021624 patent/WO1999020601A1/fr not_active Ceased
- 1998-10-16 CA CA002305798A patent/CA2305798A1/fr not_active Abandoned
- 1998-10-16 HU HU0004398A patent/HUP0004398A3/hu unknown
- 1998-10-16 BR BR9813256-3A patent/BR9813256A/pt not_active Application Discontinuation
- 1998-10-16 EP EP98953466A patent/EP1025079B1/fr not_active Expired - Lifetime
- 1998-10-16 DE DE69828895T patent/DE69828895T2/de not_active Expired - Fee Related
- 1998-10-17 TW TW087117185A patent/TWI226882B/zh not_active IP Right Cessation
2000
- 2000-04-12 NO NO20001914A patent/NO20001914L/no unknown
- 2000-07-18 US US09/529,555 patent/US6433008B1/en not_active Expired - Fee Related
- 2000-08-09 US US09/635,527 patent/US6441032B1/en not_active Expired - Fee Related
2002
- 2002-02-11 US US10/074,595 patent/US20030087957A1/en not_active Abandoned
2004
- 2004-03-05 US US10/792,910 patent/US20050124691A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US6046232A (en)	2000-04-04
ES2235374T3 (es)	2005-07-01
WO1999020601A1 (fr)	1999-04-29
ATE288419T1 (de)	2005-02-15
KR20010024520A (ko)	2001-03-26
US6441032B1 (en)	2002-08-27
CA2305798A1 (fr)	1999-04-29
SK5512000A3 (en)	2001-01-18
BR9813256A (pt)	2000-08-29
DE69828895D1 (de)	2005-03-10
DE69828895T2 (de)	2006-01-19
EP1025079A1 (fr)	2000-08-09
JP2001520217A (ja)	2001-10-30
US6433008B1 (en)	2002-08-13
TWI226882B (en)	2005-01-21
TR200001023T2 (tr)	2000-11-21
NO20001914D0 (no)	2000-04-12
AR015969A1 (es)	2001-05-30
HUP0004398A3 (en)	2001-11-28
NO20001914L (no)	2000-06-02
TNSN98187A1 (fr)	2005-03-15
EP1025079B1 (fr)	2005-02-02
NZ503910A (en)	2002-09-27
CN1281432A (zh)	2001-01-24
US20030087957A1 (en)	2003-05-08
AU1083399A (en)	1999-05-10
US20050124691A1 (en)	2005-06-09
IL135646A0 (en)	2001-05-20
PL340003A1 (en)	2001-01-15
HUP0004398A2 (hu)	2001-05-28
ID25543A (id)	2000-10-12

Publication	Publication Date	Title
MA26553A1 (fr)	2004-12-20	Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69618587D1 (de)	2002-02-21	Chinazoline und pharmazeutische zusammensetzungen
BR9500784A (pt)	1995-10-24	Composto e formulação farmacêutica
BR9504060A (pt)	1996-09-24	Composto e formulação farmacêutica
MA26507A1 (fr)	2004-12-20	Compositions pharmaceutiques d'aerosol
DZ2086A1 (fr)	2002-07-22	Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
BR1100824A (pt)	1999-08-31	Composto e composição farmacêutica
ATE263558T1 (de)	2004-04-15	Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
FI955042A7 (fi)	1995-11-29	Syklosporiinia sisältävä jauhemainen koostumus
BR9607851B1 (pt)	2009-01-13	combinaÇço e formulaÇço farmacÊutica.
IL133097A0 (en)	2001-03-19	Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
DE69524592D1 (de)	2002-01-24	2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
DE69809928D1 (de)	2003-01-16	Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
BR9507768A (pt)	1997-09-02	Composição farmacêutica
FI973229L (fi)	1997-08-05	Uusi farmaseuttinen koostumus
ID29294A (id)	2001-08-16	Komposisi farmasi
IT1274655B (it)	1997-07-18	Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
MA26531A1 (fr)	2004-12-20	Composition pharmaceutique
PT986537E (pt)	2002-12-31	Novos compostos heteroetinilenos e composicoes farmaceuticas e cosmeticas contendo-os
ZA989238B (en)	1999-05-17	Benzimidazole compounds pharmaceutical compositions containing the compounds and their use
ID25857A (id)	2000-11-09	Komposisi farmasi
FR2739382B1 (fr)	1997-11-14	Fraction ribosomale et composition la contenant
BR9606066A (pt)	1998-09-01	Composto e formulação farmacêutica